Jean Yves Blay, MD, PhD
Professor of Medical Oncology
Department of Medicine
Centre Leon Berard
Jean Yves Blay, MD, PhD, has disclosed that he has received funds for research support and consulting fees from Bayer, Blueprint, Deciphera, Novartis, PharmaMar, and Roche.
Robin L. Jones, BSc, MBBS, MRCP, MD (Res)
Royal Marsden Hospital and Institute of Cancer Research
London, United Kingdom
Robin L. Jones, BSc, MBBS, MRCP, MD(Res), has disclosed that he has received consulting fees from Adaptimmune, Astex, Athenex, Bayer, Boehringer Ingelheim, Blueprint, Clinigen, Daichii, Deciphera, Eisai, Epizyme, Immunedesign, Immunicum, Karma Oncology, Lilly, Merck, Mundipharma, PharmaMar, Spring Works, SynOx, and Tracon.